LifePoint Health (LPNT) Tops Q4 EPS by 1c

Go back to LifePoint Health (LPNT) Tops Q4 EPS by 1c

Cantor Fitzgerald Reiterates Neutral on LifePoint Health (LPNT) After Adjusting Estimates

February 21, 2017 7:00 AM EST

Cantor Fitzgerald reiterated a Neutral rating and $55.00 price target on LifePoint Health (NASDAQ: LPNT) after adjusting estimates. Cantor raised full year 2017 adjusted EPS estimates to $4.10 from $4.00, vs. the $4.13 consensus and the $4.05-$4.34 guidance. Cantor also raised adjusted EBITDA to $778 million (from $745 million) vs. the $803... More